Korean J Med.
2002 Dec;63(6):688-691.
Irinotecan (CPT-11)-induced hemorrhagic colitis
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Hallym University, Seoul, Korea. jinleeprof@hanmail.net
Abstract
- Irinotecan (CPT-11) is a chemotherapeutic agent that inhibits topoisomerase I and has shown efficacy against advanced colorectal cancer. Diarrhea is the most common toxicity that has been reported to be as high as 87% in patients treated with irinotecan. However, the serious complications including acute hemorrhagic colitis, intestinal ulceration, and intestinal perforation may be uncommon events with irinotecan therapy. We report the first Korean case of acute hemorrhagic colitis induced by irinotecan administration in the patient with advanced colon cancer.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Amoxicillin-induced Segmental Hemorrhagic Colitis
- Antibiotics Associated Hemorrhagic Colitis: A report of two cases
- Acute Hemorrhagic Colitis Associated with the Use of Oseltamivir
- Radiation Enhancement by The Combined Use of CPT-11 and Etoposide in Human Lung Cancer Cells
- Anti-epidermal growth factor receptor (EGFR) monoclonal antibody and DNA topoisomerase inhibitor reduce growth of salivary adenoid cystic carcinoma in a murine model
